Amicus Therapeutics' IPO

Amicus Therapeutics raised a round of funding on June 01, 2007. Investors include Public.

Amicus is pioneering next-generation oral therapies for the management of human genetic diseases.…

Articles about Amicus Therapeutics' IPO: